Board of Trustees of The Leland Stanford Junior University’s Arcus Biosciences RCUS Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-448,862	Closed	-$6.26M	–	27
2018 Q3	$6.26M	Sell	448,862 -176,200	-28%	-$2.25M	0.8%	6
2018 Q2	$7.65M	Hold	625,062	–	–	0.73%	7
2018 Q1	$9.65M	Buy	+625,062	New	+$10.4M	0.52%	7

Other funds holding RCUS

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's RCUS Position: Q4 2018 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Arcus Biosciences (RCUS) in Q4 2018, closing a stake of 448,862 shares — an estimated $6.26M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in RCUS in Q1 2018 and held it in 3 quarters. The position peaked at $9.65M in Q1 2018. 67 funds tracked by Wall St. Rank hold RCUS as of Q4 2018.

Board of Trustees of The Leland Stanford Junior University reported no remaining Arcus Biosciences position as of Q4 2018 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 448,862 Arcus Biosciences shares in Q4 2018, an estimated $6.26M.
Board of Trustees of The Leland Stanford Junior University first reported a position in Arcus Biosciences in Q1 2018 and held it in 3 quarters.
Board of Trustees of The Leland Stanford Junior University's Arcus Biosciences position peaked at $9.65M in Q1 2018.
67 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2018.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q4 2018, filed 12 Feb 2019.